216 related articles for article (PubMed ID: 26234677)
1. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.
Wang Y; Deng O; Feng Z; Du Z; Xiong X; Lai J; Yang X; Xu M; Wang H; Taylor D; Yan C; Chen C; Difeo A; Ma Z; Zhang J
Oncogene; 2016 Mar; 35(11):1363-72. PubMed ID: 26234677
[TBL] [Abstract][Full Text] [Related]
2. RNF126 Quenches RNF168 Function in the DNA Damage Response.
Zhang L; Wang Z; Shi R; Zhu X; Zhou J; Peng B; Xu X
Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):428-438. PubMed ID: 30529286
[TBL] [Abstract][Full Text] [Related]
3. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
[TBL] [Abstract][Full Text] [Related]
4. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
[TBL] [Abstract][Full Text] [Related]
5. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance.
Anantha RW; Simhadri S; Foo TK; Miao S; Liu J; Shen Z; Ganesan S; Xia B
Elife; 2017 Apr; 6():. PubMed ID: 28398198
[TBL] [Abstract][Full Text] [Related]
6. RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1.
Nakada S; Yonamine RM; Matsuo K
Cancer Res; 2012 Oct; 72(19):4974-83. PubMed ID: 22865450
[TBL] [Abstract][Full Text] [Related]
7. E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors.
Choi EH; Kim KP
Exp Mol Med; 2019 Sep; 51(9):1-12. PubMed ID: 31534120
[TBL] [Abstract][Full Text] [Related]
8. The BRCA1 ubiquitin ligase and homologous recombination repair.
Ohta T; Sato K; Wu W
FEBS Lett; 2011 Sep; 585(18):2836-44. PubMed ID: 21570976
[TBL] [Abstract][Full Text] [Related]
9. CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes.
Ogiwara H; Kohno T
PLoS One; 2012; 7(12):e52810. PubMed ID: 23285190
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.
Chabalier-Taste C; Brichese L; Racca C; Canitrot Y; Calsou P; Larminat F
Oncotarget; 2016 Jan; 7(3):2269-83. PubMed ID: 26745677
[TBL] [Abstract][Full Text] [Related]
11. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
[TBL] [Abstract][Full Text] [Related]
12. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
[TBL] [Abstract][Full Text] [Related]
13. Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.
Choi YE; Meghani K; Brault ME; Leclerc L; He YJ; Day TA; Elias KM; Drapkin R; Weinstock DM; Dao F; Shih KK; Matulonis U; Levine DA; Konstantinopoulos PA; Chowdhury D
Cell Rep; 2016 Jan; 14(3):429-439. PubMed ID: 26774475
[TBL] [Abstract][Full Text] [Related]
14. CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells.
Wu W; Zhao J; Xiao J; Wu W; Xie L; Xie X; Yang C; Yin D; Hu K
Biochem Biophys Res Commun; 2021 Oct; 573():62-68. PubMed ID: 34388456
[TBL] [Abstract][Full Text] [Related]
15. ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition.
Bakr A; Hey J; Sigismondo G; Liu CS; Sadik A; Goyal A; Cross A; Iyer RL; Müller P; Trauernicht M; Breuer K; Lutsik P; Opitz CA; Krijgsveld J; Weichenhan D; Plass C; Popanda O; Schmezer P
Nucleic Acids Res; 2021 Nov; 49(20):11666-11689. PubMed ID: 34718742
[TBL] [Abstract][Full Text] [Related]
16. A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer.
Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Li CY; Yang Q
Cell Cycle; 2014; 13(21):3442-9. PubMed ID: 25485588
[TBL] [Abstract][Full Text] [Related]
17. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy.
Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
[TBL] [Abstract][Full Text] [Related]
18. L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.
Zhang F; Yan P; Yu H; Le H; Li Z; Chen J; Liang X; Wang S; Wei W; Liu L; Zhang Y; Ji X; Xie A; Chen W; Han Z; Pu WT; Chen S; Chen Y; Sun K; Ge B; Zhang B
Cell Rep; 2020 Jul; 32(4):107974. PubMed ID: 32726637
[TBL] [Abstract][Full Text] [Related]
19.
Poh W; Dilley RL; Moliterno AR; Maciejewski JP; Pratz KW; McDevitt MA; Herman JG
Clin Cancer Res; 2019 Apr; 25(8):2513-2522. PubMed ID: 30692098
[TBL] [Abstract][Full Text] [Related]
20. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
